Cymabay Therapeutics Inc sell Midas
Start price
12.02.21
/
50%
€4.80
Target price
12.02.22
-
Performance (%)
-36.21%
End price
25.08.21
€3.06
Summary
This prediction ended on 25.08.21 with a price of €3.06. The SELL prediction by Midas for Cymabay Therapeutics Inc performed very well with a performance of -36.21%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cymabay Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % | 58,55 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % | 80,51 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % | 62,78 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % | 54,39 % |
Comments by Midas for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Sell Cymabay Therapeutics Inc